Home › Therapeutic areas › Metabolic › Classical Homocystinuria

Classical Homocystinuria (2 companies)

Companies with an active program in Classical Homocystinuria.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+3 Rare 1 Approved $1.84B 17
TVTX Travere Therapeutics MetabolicRenal Rare 1 Approved $4.91B 7